Generic Biologics Bill Still Has Good Chance For Enactment This Year – Waxman, Pallone
This article was originally published in The Pink Sheet Daily
Executive Summary
Key House legislators assure generics industry that they remain committed to generic biologics legislation, though PDUFA will move ahead without it.
You may also be interested in...
Follow-On Biologics Deal Gives Brands 12 Years Of Exclusivity
A senate markup is scheduled for June 27 on legislation to create abbreviated BLA approval pathway.
IFRA Hosts Capitol Hill Scent Experience In Timeout From Policy Concerns
The International Fragrance Association North America took a break from its higher-stakes advocacy work Nov. 1 to give lawmakers and congressional staffers a "scent experience." Perfumers from six of the group's biggest members were on hand with "Scents of Home," joined by Monell Center researchers to educate attendees on the mechanics of scent and the important role it plays in people's lives.
NSF's Cosmetics Verification Program Fizzles, While EWG's Could See Second Boom
NSF International has put its cosmetic product verification program on ice due to lack of interest since its launch in April 2017. Meanwhile, more than 1,000 products from 75+ brands have earned the "EWG Verified" mark, and the NGO says interest is higher than ever following Walmart's announcement in September that it will begin pushing vendors to pursue the verification.